Longer-term follow up in the FLAURA2 Phase III trial confirms the favourable benefit-risk profile of this combination
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
Capricor’s BLA for Deramiocel received Priority Review in March 2025
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
In collaboration with the Gates Foundation, Merck advances MK-8527 pre-exposure prophylaxis (PrEP) clinical trials globally
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
It is intended for contrast enhancement in MRI scans
Apollo AyurVAID’s product line features clinically proven formulations certified safe by NABL-accredited laboratories for heavy metals, aflatoxins, microbial content
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Subscribe To Our Newsletter & Stay Updated
